期刊文献+

22例重症社区获得性肺炎的临床分析 被引量:4

Clinical data analysis of 22 cases of severe community-acquired pneumonia
下载PDF
导出
摘要 目的了解重症社区获得性肺炎的临床流行病学特点、疗效和预后。方法回顾22例重症社区获得性肺炎住院患者的临床资料。结果治愈19例,死亡3例,治疗有效率86.4%,死亡率13.6%。死亡原因分别为合并肾功能衰竭、严重免疫力低下性疾病。结论重症社区获得性肺炎常伴呼吸衰竭,合并症多,机体免疫力低下,病原体检测阴性率高,及时采取经验性降阶梯抗感染、免疫增强治疗及提高病原体检测阳性率是提高治愈率的关键,免疫力低下相关性感染预后差。 Objective To understand the clinical epidemiological characteristics,therapeutic effect and prognosis of severe community-acquired pneumonia.Methods Clinical data of 22 inpatients with several community-acquired pneumonia were retrospectively analyzed.Results 19 patients were cured and 3 patients died.The effective rate and the mortality rate were respectively 86.4% and 13.6%.The causes of death were renal failure,severe low level of immunity.Conclusion Severe community-acquired pneumonia is often complicated by respiratory failure or other complications.Positive detection rate was low.To increase the treatment effect,attention should be given to de-graded anti-infection,enhancement of immunity and increase of positive detection of pathogen.Unsatisfactory prognosis occurred most among low-immunity-related infection patients.
出处 《临床肺科杂志》 2008年第9期1107-1108,共2页 Journal of Clinical Pulmonary Medicine
关键词 重症社区获得性肺炎 临床分析 预后 severe community-acquired pneumonia clinical analysis prognosis
  • 相关文献

参考文献3

二级参考文献29

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Alves DW, Kennedy MT. Community-Acquired pneumonia in casualty : Etiology, Clinical Features, Diagnosis, and Management. Curr Opin Pulm Med,2004,10:166 - 170. 被引量:1
  • 4Torres A, Muir J, Corris P, Kubin R, et al. Effectiventess of oral moxifloxacin in standard first-lin therapy in community-acquired pneumonia. Eur Respir J, 2003,21:135 - 143. 被引量:1
  • 5Drummond M, Becker D, Hux M, et al. An Economic Evaluation of Sequential Ⅳ/po Moxifloxacin Therapy Compared to Ⅳ/po Coamoxiclav with without clarithromycin in the treatment of community-acquired pneumonia. Chest,2003,124:526-535. 被引量:1
  • 6Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量:1
  • 7de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351. 被引量:1
  • 8Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659. 被引量:1
  • 9Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936. 被引量:1
  • 10Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421. 被引量:1

共引文献3097

同被引文献41

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部